SHPHF (Sihuan Pharmaceutical Holdings Group) Graham Number: $0.06 (As of Dec. 2025) — 95% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHPHF Sihuan Pharmaceutical Holdings Group Ltd SHPHF
52 GF Score
Price $0.12
GF Value $0.15
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Sihuan Pharmaceutical Holdings Group Graham Number?

Sihuan Pharmaceutical Holdings Group SHPHF 52 Graham Number is $0.06 as of Dec. 2025, which is 95% below its 10-year median of 1.17. GuruFocus rates SHPHF with a GF Scoreâ„¢ of 52/100 and a GF Valueâ„¢ of $0.15 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 604 Drug Manufacturers companies, Sihuan Pharmaceutical Holdings Group ranks worse than 60.26% on this metric.

Graham Number is a figure that measures a stock's fundamental value by taking into account the company's earnings per share and book value per share. The Graham number is the upper bound of the price range that a defensive investor should pay for the stock. According to the theory, any stock price below the Graham number is considered undervalued, and thus worth investing in.

As of today (2026-07-20), the stock price of Sihuan Pharmaceutical Holdings Group is $0.12. Sihuan Pharmaceutical Holdings Group's graham number for the quarter that ended in Dec. 2025 was $0.06. Therefore, Sihuan Pharmaceutical Holdings Group's Price to Graham Number ratio for today is 2.04.

The historical rank and industry rank for Sihuan Pharmaceutical Holdings Group's Graham Number or its related term are showing as below:

SHPHF' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 0.71   Med: 1.17   Max: 2.54
Current: 1.71

During the past 13 years, the highest Price to Graham Number ratio of Sihuan Pharmaceutical Holdings Group was 2.54. The lowest was 0.71. And the median was 1.17.

SHPHF's Price-to-Graham-Number is ranked worse than
60.26% of 604 companies
in the Drug Manufacturers industry
Industry Median: 1.53 vs SHPHF: 1.71

Graham Number is a combination of asset valuation and earnings power valuation. It is a very conservative way of valuing a stock.


Sihuan Pharmaceutical Holdings Group  (OTCPK:SHPHF) Graham Number Explanation

Ben Graham actually did not publish a formula like this. But he wrote in The Intelligent Investor (1948 version) regarding to the criteria for purchases:

Current price should not be more than 15 times average earnings of the past three years.

Current price should not be more than 1.5 times the book value last reported. However, a multiplier of earnings below 15 could justify a correspondingly higher multiplier of assets. As a rule of thumb we suggest that the product of the multiplier times the ratio of price to book value should not exceed 22.5. (This figure corresponds to 15 times earnings and 1.5 times book value. It would admit an issue selling at only 9 times earnings and 2.5 times asset value, etc.)

Unlike valuation methods such as DCF or Discounted Earnings, the Graham number does not take growth into the valuation. Unlike the valuation methods based on book value alone, it takes into account the earnings power. Therefore, the Graham Number is a combination of asset valuation and earnings power valuation.

In general, the Graham number is a very conservative way of valuing a stock. It cannot be applied to companies with negative book values.

Sihuan Pharmaceutical Holdings Group's Price to Graham number Ratio for today is calculated as

Price to Graham number=Share Price (Today)/Graham number (Q: Dec. 2025 )
=0.12/0.06
=2.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Please keep these in mind:

1. Graham Number does not take growth into account. Therefore it underestimates the values of the companies that have good earnings growth. We feel that if the earnings per share grows more than 10% a year, Graham Number underestimates the value.
2. Graham Number punishes the companies that have temporarily low earnings. Therefore, an average of earnings makes more sense in the calculation of Graham Number.
3. Graham Numbers underestimates companies that are light with book.


Sihuan Pharmaceutical Holdings Group Graham Number Related Terms


Sihuan Pharmaceutical Holdings Group Graham Number Historical Data

* Premium members only.

The historical data trend for Sihuan Pharmaceutical Holdings Group's Graham Number can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sihuan Pharmaceutical Holdings Group Graham Number Chart

Sihuan Pharmaceutical Holdings Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Graham Number
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.15 0.00 0.00 0.00 0.06

Sihuan Pharmaceutical Holdings Group Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Graham Number Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.06

SHPHF vs ZTS, UTHR: Graham Number Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Sihuan Pharmaceutical Holdings Group's Price-to-Graham-Number, along with its competitors' market caps and Price-to-Graham-Number data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sihuan Pharmaceutical Holdings Group Price-to-Graham-Number vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sihuan Pharmaceutical Holdings Group's Price-to-Graham-Number distribution charts can be found below:

* The bar in red indicates where Sihuan Pharmaceutical Holdings Group's Price-to-Graham-Number falls into.


SHPHF
52GF Score
Sihuan Pharmaceutical Holdings Group Ltd SHPHF
Graham Number is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sihuan Pharmaceutical Holdings Group Graham Number Calculation

Graham Number is a concept based on Ben Graham's conservative valuation of companies.

Sihuan Pharmaceutical Holdings Group's Graham Number for the fiscal year that ended in Dec. 2025 is calculated as

Graham Number
=sqrt of (22.5* Tangible Book per Share *EPS without NRI)
=sqrt of (22.5*0.077*0.002)
=0.06

Sihuan Pharmaceutical Holdings Group's Graham Number for the quarter that ended in Dec. 2025 is calculated as

Graham Number
=sqrt of (22.5*Tangible Book per Share*EPS without NRI (TTM))
=sqrt of (22.5*0.077*0.002)
=0.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Graham Number →
What does a Graham Number of $0.06 mean?
Sihuan Pharmaceutical Holdings Group (SHPHF) has a Graham Number of $0.06 as of Dec. 2025. The Graham Number values a company based on its per-share earnings and book value. View historical data on Sihuan Pharmaceutical Holdings Group and its competitors. This is 95% below median its historical median of 1.17. Over the past decade, Sihuan Pharmaceutical Holdings Group's Graham Number has ranged from 0.71 to 2.54. According to the industry distribution chart, Sihuan Pharmaceutical Holdings Group ranks #364 out of 604 companies in the Drug Manufacturers industry, placing it in the top 60.3%.
Is Sihuan Pharmaceutical Holdings Group's Graham Number too high?
Sihuan Pharmaceutical Holdings Group's current Graham Number of $0.06 is 95% below median its 10-year median of 1.17. Over the past 10 years, this metric has ranged from a low of 0.71 to a high of 2.54. The Drug Manufacturers industry median Graham Number is 1.53. Sihuan Pharmaceutical Holdings Group's value of $0.06 is 96.1% below this industry median. Based on the distribution chart, Sihuan Pharmaceutical Holdings Group ranks #364 out of 604 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Sihuan Pharmaceutical Holdings Group has a GF Scoreâ„¢ of 52/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sihuan Pharmaceutical Holdings Group's Graham Number compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Sihuan Pharmaceutical Holdings Group ranks #364 out of 604 companies for Graham Number. This places Sihuan Pharmaceutical Holdings Group in the lower half of its industry. The industry median Graham Number is 1.53. Sihuan Pharmaceutical Holdings Group's value of $0.06 is 96.1% below this benchmark. Historically, Sihuan Pharmaceutical Holdings Group's own Graham Number has ranged from 0.71 to 2.54 over the past decade. While the company's 10-year median is 1.17 vs. the industry median of 1.53, Sihuan Pharmaceutical Holdings Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Graham Number for a Drug Manufacturers company?
The median Graham Number among Drug Manufacturers companies is 1.53, based on 604 companies in the industry. Companies in the top quartile (top 25%) have a Graham Number significantly above this median, while those in the bottom quartile fall well below. However, Graham Number should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sihuan Pharmaceutical Holdings Group's current Graham Number of $0.06 is 96.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Graham Number mean?
A high Graham Number can signal that a stock is expensive relative to its fundamentals. The Graham Number values a company based on its per-share earnings and book value. View historical data on Sihuan Pharmaceutical Holdings Group and its competitors. For the Drug Manufacturers industry, the median Graham Number is 1.53 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sihuan Pharmaceutical Holdings Group's current Graham Number is $0.06, which is 95% below median its own 10-year median of 1.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sihuan Pharmaceutical Holdings Group stock overvalued right now?
Based on GuruFocus' analysis, Sihuan Pharmaceutical Holdings Group (SHPHF) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.15, compared to a current price of $0.12 — trading 20% below its estimated fair value. The current Graham Number is $0.06, which is 95% below median its 10-year median of 1.17 and 96.1% below the Drug Manufacturers industry median of 1.53. Sihuan Pharmaceutical Holdings Group's overall GF Score™ is 52/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Graham Number calculated?
Graham Number is calculated from a company's financial statements. For Sihuan Pharmaceutical Holdings Group (SHPHF), the current Graham Number is $0.06 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sihuan Pharmaceutical Holdings Group (SHPHF) Overvalued in 2026?

Based on GuruFocus' analysis, Sihuan Pharmaceutical Holdings Group stock appears to be undervalued. The current stock price of $0.12 is trading 20% below its estimated GF Value™ of $0.15. GuruFocus considers Sihuan Pharmaceutical Holdings Group to be Modestly Undervalued.

Key valuation signals for SHPHF:

  • Graham Number: $0.06 (95% below median its 10-year median of 1.17)
  • GF Value™: $0.15 vs. price of $0.12 (20% below fair value)
  • GF Score™: 52/100 with 4 warning signs
  • Industry Position: 96.1% below the Drug Manufacturers median (#364 of 604)

No single metric tells the full story. See the SHPHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sihuan Pharmaceutical Holdings Group Business Description

Other Exchanges 00460:Hong KongTEL1:Germany
Address 1 Harbour Road, Convention Plaza, Room 4905, Office Tower, Wanchai, HKG
Sihuan Pharmaceutical Holdings Group Ltd is an investment holding company. Along with its subsidiaries, the company is engaged in the research & development and the manufacture & sale of pharmaceutical products. Its portfolio comprises products for diseases related to the cardio-cerebral vascular (CCV) system, Respiratory, Neurology, and others. The group has three reportable segments: the medical aesthetic products segment, including the filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skincare, and others; the innovative medicine and other medicine segment; and the generic medicine segment, which generates key revenue. Geographically, the company generates a majority of its revenue from Mainland China and the rest from the United States.
52GF Score

Get the complete analysis for SHPHF

Graham Number is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.12
Price
$0.15
GF Value